Prognostic Factors Influencing the Result of Postoperative Radiotherapy in Endometrial Carcinoma
![]() |
Ki Yong-Kan
(Departments of Radiation Oncology and Pusan National University School of Medicine)
Kwon Byung-Hyun (Departments of Radiation Oncology and Pusan National University School of Medicine) Kim Won-Taek (Departments of Radiation Oncology and Pusan National University School of Medicine) Nam Ji-Ho (Departments of Radiation Oncology and Pusan National University School of Medicine) Yun Man-Su (Obstetrics and Gynecology, Pusan National University School of Medicine) Lee Hyung-Sik (Department of Radiation Oncology, Dong-A University School of Medicine) Kim Dong-Won (Departments of Radiation Oncology and Pusan National University School of Medicine) |
1 | Berek JS, Haker NF. Practical gynecologic oncology. 3rd ed. Philadelphia; Lippincott Williams, Wilkins, 2000:407-455 |
2 | Amant F, Cadron I, Fuso L, et al. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol Oncol 2005;98:274-280 DOI ScienceOn |
3 | Lurain JR, Rice BL, Rademaker AW, Proggensee LE, Schink JC, Miller DS. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1991;78:63-69 |
4 | Jereczek-fossa B, Badzio A, Jassem J. Surgery followed by radiotherapy in endometrial cancer: analysis of survival and pattern of failure. Int J Gynecol Cancer 1999;9:285-294 DOI ScienceOn |
5 | Kuten A, Grigsby PW, Perez CA, Fineberg B, Garcia DM, Simpson JR. Results of radiotherapy in recurrent endometrial carcinoma: a retrospective analysis of 51 patients. Int J Radiat Oncol Biol Phys 1989;17:29-34 DOI ScienceOn |
6 | Descamps P, Calais G, Moire C, et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol Oncol 1997;64:54-58 DOI ScienceOn |
7 | Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium. Gyecol Oncol 1991;40:55-65 DOI ScienceOn |
8 | Scholten AN, Cresutzberg CL, Noordijk EM, Smit VT. Long-term outcome in endometrial carcinoma favors a two-instead of a three-tiered grading system. Int J Radiat Oncol Biol Phys 2002;52:1067-1074 DOI ScienceOn |
9 | Zanio RJ, Kurman RJ, Diana KL, Morrow CP. Pathologic models to predict outcome for women with endometrial adenocarcinoma. Cancer 1996;77:1115-1121 DOI ScienceOn |
10 | Jemal A, Murray T, Samuels A, et al. Cancer statics, 2004. CA Cancer J Clin 2004;54:8-29 DOI ScienceOn |
11 | Lentz SS, Brady MF, Major FJ, Redi GC, Soper JT. Highdose megesterol acetate in advanced or recurrent endometrial carcinoma: a gynecologic oncologic group study. J Clin Oncol 2004;14:357-361 |
12 | Aalders JG, vd Syde R, Poppema S, Szabo BG, Janssens J. Prognostic factors and changing trends in the treatment of Stage I endometrial cancer: a clinical and histopathological study of 182 patients. Int J Radiat Oncol Biol Phys 1984;10: 2083-2088 DOI ScienceOn |
13 | Ministry of Health and Welfare, R.O.K. 2002 Annual Report of the Korea Central Cancer Registry 2003 |
14 | Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma. Gynecol Oncol 2004;94:241-242 DOI ScienceOn |
15 | Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 2006;24: 36-44 DOI ScienceOn |
16 | Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, et al. Outcome of high risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol 2004;22:1234-1241 DOI ScienceOn |
17 | Thigpen JT, Brady MF, Homesley HD, et al. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 2004;22:3902-3908 DOI ScienceOn |
18 | Thigpen JT, Brady MF, Alvarez RD, et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the gynecologic oncologic group. J Clin Oncol 1999;17:1736- 1744 DOI |
19 | Briet JM, Hollema H, Reesink N, et al. Lymphovascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 2005;96:799-804 DOI ScienceOn |
![]() |